Recent

% | $
Quotes you view appear here for quick access.

Seattle Genetics, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • redhot47fla redhot47fla Nov 13, 2012 10:58 AM Flag

    New Credit Suisse Rating

    Especially like these parts: "We view SGEN as a must own pure-play antibody company, with a leadership position in the field of antibody-drug conjugates, an area of increasing investor and pharmaceutical company interest.... Quarterly sales are important in the near-term, but not as important as investor confidence in market expansion opportunities."

    Thanks for sharing it, biogeny.

 
SGEN
43.98-1.14(-2.53%)Aug 25 4:00 PMEDT